Latinx Hazardous Drinkers with Clinical Anxiety: Effectiveness Trial of a Personalized Normative Feedback Intervention

患有临床焦虑的拉丁裔危险饮酒者:个性化规范反馈干预的有效性试验

基本信息

  • 批准号:
    10369165
  • 负责人:
  • 金额:
    $ 14.65万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-09-20 至 2026-05-31
  • 项目状态:
    未结题

项目摘要

Project Summary/Abstract Despite being one of the largest and fastest-growing demographics in the United States (US), Latinx persons experience striking health disparities, particularly in terms of hazardous drinking and co-occurring clinical anxiety. No interventions to date have targeted hazardous drinking in the context of clinical anxiety among Latinx persons. The current R01 proposal builds upon our past work by developing a brief, single-session, computer-based, personalized feedback intervention (PFI) designed to enhance knowledge regarding adverse anxiety-alcohol interrelations, increase motivation and intention to reduce hazardous drinking, and reduce positive attitudes and intentions regarding the use of alcohol for anxiety. Specifically, we propose to develop a low-cost, highly disseminatable, integrated PFI for Latinx hazardous drinkers with clinical anxiety (AA-PFI 1.0) that will be implemented and tested for effectiveness in community-based health clinics. Our approach will follow a staged model consistent with National Institutes of Health (NIH) guidelines for developing and standardizing behavioral interventions. Phase IA activities will involve collecting qualitative and quantitative feedback from three iterative focus groups (N = 21) to refine intervention content and evaluate treatment acceptability and feasibility. Phase IB activities will include a rigorous randomized clinical trial designed to compare the effectiveness of AA-PFI 2.0 to a control PFI (C-PFI) among a sample of 250 Latinx hazardous drinkers with clinical anxiety who receive care within community-based health clinics. This study represents an important and pivotal step in the larger landscape of translating basic research to more efficacious strategies for reducing hazardous drinking in underserved populations with biobehavioral comorbidities. The proposed research project supports the 2017-2021 strategic plan of the National Institute on Alcohol Abuse and Alcoholism (NIAAA) by advancing research in two of the key areas. First, the current proposal has the end goal of improving strategies to prevent alcohol misuse, alcohol use disorder, and alcohol-related consequences among an ‘at-risk’ population for these conditions (goal 3). Second, it enhances the public health impact of NIAAA-supported research by focusing on one of the fastest-growing and largest demographics in the US who demonstrate disparities in hazardous drinking (goal 5). The current application aligns with the goals of RFA- AA-21-001 by proposing to examine the effectiveness of a low cost, highly disseminatable, personalized, culturally adapted PFI for Latinx hazardous drinkers with clinical anxiety within community-based health clinics. Given the collective public health impact of concurrent anxiety and alcohol use, we believe the proposed study will yield findings that enhance scientific knowledge, advance our understanding of mechanisms in anxiety- alcohol use relations, and inform the development of novel treatments for hazardous drinkers with clinical anxiety that are adaptable and easily implemented across a variety of healthcare settings.
项目概要/摘要 尽管拉丁裔是美国人口规模最大、增长最快的群体之一,但 经历显着的健康差异,特别是在危险饮酒和同时发生的临床症状方面 迄今为止,还没有针对临床焦虑背景下的危险饮酒的干预措施。 当前的 R01 提案以我们过去的工作为基础,制定了一个简短的、单次会议的、 基于计算机的个性化反馈干预(PFI),旨在增强有关不良反应的知识 焦虑与酒精的相互作用,增加减少有害饮酒的动机和意图,并减少 具体来说,我们建议制定一个关于使用酒精治疗焦虑的积极态度和意图。 针对具有临床焦虑的拉丁裔危险饮酒者的低成本、高度传播的综合 PFI(AA-PFI 1.0) 我们的方法将在社区卫生诊所中实施并测试其有效性。 遵循符合美国国立卫生研究院 (NIH) 指南的分阶段模型来开发和 标准化行为干预措施将涉及收集定性和定量的信息。 来自三个迭代焦点小组 (N = 21) 的反馈,以完善干预内容并评估治疗 IB 期活动将包括严格的随机临床试验,旨在 在 250 个拉丁裔危险样本中比较 AA-PFI 2.0 与对照 PFI (C-PFI) 的有效性 这项研究代表了在社区健康诊所接受护理的患有临床焦虑症的饮酒者。 将基础研究转化为更有效策略的大格局中重要且关键的一步 减少患有生物行为合并症的服务不足人群的危险饮酒。 研究项目支持国家酒精滥用研究所 2017-2021 年战略计划 酒精中毒(NIAAA)通过推进两个关键领域的研究首先,当前的提案有最终目标。 改进酒精预防滥用、酒精使用障碍和酒精相关后果的策略 其次,它增强了这些疾病的“高危”人群(目标 3)。 NIAAA 支持的研究重点关注美国增长最快和最大的人口统计数据之一 展示危险饮酒的差异(目标 5)。当前的应用与 RFA 的目标一致。 AA-21-001 提议检查低成本、高度传播、个性化、 针对社区卫生诊所内患有临床焦虑症的拉丁裔危险饮酒者进行文化适应的 PFI。 考虑到同时焦虑和饮酒对公共健康的集体影响,我们认为拟议的研究 将产生增强科学知识、增进我们对焦虑机制的理解的发现 酒精使用关系,并通过临床为有害饮酒者开发新的治疗方法提供信息 焦虑症具有适应性,并且可以在各种医疗保健环境中轻松实施。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MICHAEL J. ZVOLENSKY其他文献

MICHAEL J. ZVOLENSKY的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MICHAEL J. ZVOLENSKY', 18)}}的其他基金

Latinx Hazardous Drinkers with Clinical Anxiety: Effectiveness Trial of a Personalized Normative Feedback Intervention
患有临床焦虑的拉丁裔危险饮酒者:个性化规范反馈干预的有效性试验
  • 批准号:
    10616033
  • 财政年份:
    2021
  • 资助金额:
    $ 14.65万
  • 项目类别:
Latinx Hazardous Drinkers with Clinical Anxiety: Effectiveness Trial of a Personalized Normative Feedback Intervention
患有临床焦虑的拉丁裔危险饮酒者:个性化规范反馈干预的有效性试验
  • 批准号:
    10836087
  • 财政年份:
    2021
  • 资助金额:
    $ 14.65万
  • 项目类别:
Latinx Hazardous Drinkers with Clinical Anxiety: Effectiveness Trial of a Personalized Normative Feedback Intervention
患有临床焦虑的拉丁裔危险饮酒者:个性化规范反馈干预的有效性试验
  • 批准号:
    10491117
  • 财政年份:
    2021
  • 资助金额:
    $ 14.65万
  • 项目类别:
Latinx Hazardous Drinkers with Clinical Anxiety: Effectiveness Trial of a Personalized Normative Feedback Intervention
患有临床焦虑的拉丁裔危险饮酒者:个性化规范反馈干预的有效性试验
  • 批准号:
    10631222
  • 财政年份:
    2021
  • 资助金额:
    $ 14.65万
  • 项目类别:
Improving Access to Cigarette Cessation Treatment Among African American Smokers: Development and Evaluation of an Integrated mHealth Application
改善非裔美国吸烟者获得戒烟治疗的机会:综合移动医疗应用程序的开发和评估
  • 批准号:
    10259792
  • 财政年份:
    2020
  • 资助金额:
    $ 14.65万
  • 项目类别:
Improving Access to Cigarette Cessation Treatment Among African American Smokers: Development and Evaluation of an Integrated mHealth Application
改善非裔美国吸烟者获得戒烟治疗的机会:综合移动医疗应用程序的开发和评估
  • 批准号:
    10381567
  • 财政年份:
    2020
  • 资助金额:
    $ 14.65万
  • 项目类别:
Improving Access to Cigarette Cessation Treatment Among African American Smokers: Development and Evaluation of an Integrated mHealth Application
改善非裔美国吸烟者获得戒烟治疗的机会:综合移动医疗应用程序的开发和评估
  • 批准号:
    10644994
  • 财政年份:
    2020
  • 资助金额:
    $ 14.65万
  • 项目类别:
Integrated Smoking Cessation Treatment for Emotional Dysregulation
针对情绪失调的综合戒烟治疗
  • 批准号:
    8423889
  • 财政年份:
    2013
  • 资助金额:
    $ 14.65万
  • 项目类别:
Integrated Smoking Cessation Treatment for Emotional Dysregulation
针对情绪失调的综合戒烟治疗
  • 批准号:
    8650809
  • 财政年份:
    2013
  • 资助金额:
    $ 14.65万
  • 项目类别:
Smoking-Based Prevention Program for Panic Disorder
基于吸烟的恐慌症预防计划
  • 批准号:
    7541070
  • 财政年份:
    2007
  • 资助金额:
    $ 14.65万
  • 项目类别:

相似国自然基金

分子生物学联合CT血管成像研究不同种类酒及饮酒量对猪血管弹性的作用机制
  • 批准号:
    81371548
  • 批准年份:
    2013
  • 资助金额:
    75.0 万元
  • 项目类别:
    面上项目

相似海外基金

Longitudinal Modeling of Pro-Inflammatory Cytokines, Hazardous Alcohol Use, and Cerebral Metabolites as Predictors of Neurocognitive Change in People with HIV
促炎细胞因子、有害酒精使用和脑代谢物的纵向建模作为 HIV 感染者神经认知变化的预测因子
  • 批准号:
    10838849
  • 财政年份:
    2024
  • 资助金额:
    $ 14.65万
  • 项目类别:
Effects of tACS on alcohol-induced cognitive and neurochemical deficits
tACS 对酒精引起的认知和神经化学缺陷的影响
  • 批准号:
    10825849
  • 财政年份:
    2024
  • 资助金额:
    $ 14.65万
  • 项目类别:
Identification of Prospective Predictors of Alcohol Initiation During Early Adolescence
青春期早期饮酒的前瞻性预测因素的鉴定
  • 批准号:
    10823917
  • 财政年份:
    2024
  • 资助金额:
    $ 14.65万
  • 项目类别:
Developing and Evaluating a Positive Valence Treatment for Alcohol Use Disorder with Anxiety or Depression
开发和评估治疗伴有焦虑或抑郁的酒精使用障碍的正价疗法
  • 批准号:
    10596013
  • 财政年份:
    2023
  • 资助金额:
    $ 14.65万
  • 项目类别:
Targeting Alcohol-Opioid Co-Use Among Young Adults Using a Novel MHealth Intervention
使用新型 MHealth 干预措施针对年轻人中酒精与阿片类药物的同时使用
  • 批准号:
    10456380
  • 财政年份:
    2023
  • 资助金额:
    $ 14.65万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了